Search results
Psoriasis pain: Prevalence and how to manage it
Medical News Today· 2 days agoPeople may describe psoriasis pain as itchy, achy, or stinging, with the feeling varying from person to person. Strategies such as using distraction,...
Nail Psoriasis: Causes, Symptoms, and How to Treat It
Allure via Yahoo News· 7 days agoNail psoriasis is a little-discussed aspect of the common skin condition. Dermatologists explain the...
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 7 days agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos,...
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 2 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent of people with ...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 24 hours agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
FDA Roundup: April 26, 2024
KOLR - KSFX Ozarks· 7 days agoThis represents the first FDA approval of a systemic therapy for the treatment of patients with pediatric LGG with BRAF rearrangements, including fusions. Full prescribing ...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 1 day agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 7 days agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
Children With Chronic Skin Disorders Face Substantial Stigma
Medscape· 4 days agoHealthcare professionals should be aware of the possibility of stigmatization and bullying when...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
